The Globe and Mail reports in its Thursday, Aug. 15, edition that RBC Dominion Securities analyst Darko Mihelic has reaffirmed his "outperform" recommendation for Sun Life Financial. The Globe's David Leeder writes in the Eye On Equities column that Mr. Mihelic gave his share target a $2 boost to $78. Analysts on average target the shares at $75.92. Mr. Mihelic says in a note: "Sun Life reported a solid quarter with stronger than expected results in many areas (Canada, the U.S. and Asia). We continued to see some weakness in the U.S. dental business but it seems that this business is past the worst of it and that we should see a rebound in earnings contribution next year. Similarly, there will be a small lift from restructuring into 2025 and some level of 'normalization' even in wealth. Sun Life has solid capital levels (cash at holdco, strong LICAT ratio, renewed NCIB) so all in, we see a solid setup into 2025. ... Changes to our model mainly reflect higher results in Canada and U.S. from higher other fee income, better earnings in Asia primarily due to higher joint venture and other results than our previous estimates, and 2.1 million shares in buybacks per quarter in the next four quarters under the renewed NCIB."